AJG director granted 194 shares in compensation
Arthur J. Gallagher & Co. director Christopher C. Miskel acquired 194.081 shares of common stock on June 1, 2026 at a reference price of $206.10 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arthur J. Gallagher & Co. director Christopher C. Miskel acquired 194.081 shares of common stock on June 1, 2026 at a reference price of $206.10 per share. This was a grant under the company’s Director Deferral Plan, converting deferred cash retainers into share units, bringing his direct holdings to 10,641.773 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 194.081 | $206.10 | $40K |
Footnotes (1)
- F1. This acquisition resulted from the reporting person's election in a prior year (pursuant to the Company's Director Deferral Plan) to defer the reporting person's annual cash retainer, which the Company pays on a quarterly basis, into deferred share units that will be distributed in the form of the Company's common stock.
Key Figures
Key Terms
Director Deferral Plan financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Arthur J. Gallagher (AJG) disclose for Christopher C. Miskel?
Was the AJG Form 4 transaction by Christopher Miskel an open-market purchase or a grant?
What is Christopher Miskel’s total direct ownership in Arthur J. Gallagher (AJG) after this transaction?
What role does Arthur J. Gallagher’s Director Deferral Plan play in this AJG Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.